Medication info
Ravis Tablet

Ravis Tablet

Prescription medicationTabletOral
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
IYOUN Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 201708043 · Approved 2017.11.23

Summary

Main use
Treatment of acid-related disorders (ulcers, gastritis, etc.); prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
Usually, administer 2 tablets orally twice daily, regardless of food, in the morning and before bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and before bedtime. The dose is the same when used in combination to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks, and usually within 8 weeks; however, healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily, and increase the dose as needed. In cases of severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
IYOUN Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, gastritis, etc.); prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by NSAIDs
View approved original text

This medication is used for the treatment of gastrointestinal disorders such as gastric and duodenal ulcers, gastritis, and gastroesophageal reflux disease. It also helps control excessive gastric acid secretion, such as in Zollinger-Ellison syndrome. It is effective in preventing postoperative ulcers and treating ulcers caused by NSAIDs (non-steroidal anti-inflammatory drugs). It is also used to prevent Mendelson's syndrome through pre-anesthetic administration. It is a medication used to improve various gastrointestinal disorders.

How to take

Adult dose

Usually, administer 2 tablets orally twice daily, regardless of food, in the morning and before bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and before bedtime. The dose is the same when used in combination to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks, and usually within 8 weeks; however, healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily, and increase the dose as needed. In cases of severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or those with renal impairment. It should also not be administered to patients who have had an allergic reaction to this drug or its components, those with a history of acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants and newborns, and patients on a potassium-restricted diet. Caution should be exercised in patients with liver impairment, a history of drug allergies, elderly patients, those with a history of renal dysfunction, and patients taking NSAIDs. It may conceal symptoms of gastric cancer, so patients with gastric ulcers or those over middle age who have recently developed or changed dyspeptic symptoms should confirm that it is not a malignant disease before using this medication. Patients with gastritis with a positive Helicobacter pylori infection need treatment to eradicate the bacteria, and caution should be taken in critically ill patients or those with hypophosphatemia and swallowing difficulties. Rarely, during the use of this medication, side effects such as shock, skin rash, urticaria, blood abnormalities, liver dysfunction, arrhythmias, gastrointestinal symptoms, neuropsychiatric symptoms, myalgia, skin abnormalities, etc. can occur, so if symptoms appear, immediate consultation with a healthcare professional is necessary. Do not take this medication continuously for long periods, and periodically monitor symptoms and liver and kidney function during treatment. Particularly, elderly patients and those with chronic pulmonary disease, diabetes, or immunocompromised conditions may have an increased risk of pneumonia, so caution is warranted, and if dizziness or drowsiness occurs, driving or operating dangerous machinery should be avoided. This medication may interact with other drugs, so be sure to inform your healthcare provider of any medications you are currently taking, as some drugs may alter the effects of this medication, necessitating dosage adjustments or discontinuation. Pregnant or breastfeeding women are advised not to use this medication, and safety and efficacy for children have not been established, so its use is not recommended. In case of overdose, procedures such as vomiting or gastric lavage may be necessary, and if required, hemodialysis may be used to remove the drug. Finally, this medication reduces gastric acid secretion, which can promote bacterial growth in the gastrointestinal tract, so regular examinations including eye tests are required for prolonged use.

Side effects

  • anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • agranulocytosis
  • leukopenia
Show 56 more
  • thrombocytopenia
  • increased serum enzyme levels
  • aplastic anemia
  • pancytopenia
  • bone marrow hypoplasia
  • bone marrow aplasia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • increased AST
  • increased ALT
  • increased r-GTP
  • increased ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsion
  • agitation
  • insomnia
  • headache
  • heaviness of the head
  • malaise
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disturbances
  • myoclonus
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • joint pain
  • muscle pain
  • rhabdomyolysis
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. It is recommended to maintain the storage temperature between 1 to 30 degrees Celsius to preserve the efficacy of the medication.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.